Clinical Trial

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

Name: Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction — clinical trial record (NCT07082816)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Protocol Amendment History 1 change

critical Trial completed 2026-04-22

Trial Details

NCT Number	NCT07082816
Lead Sponsor	Alcon Research
Conditions	Ocular Hypertension, Open Angle Glaucoma
Enrollment	489 participants
Start Date	2025-09-02
Primary Completion	2026-04-06 (estimated)
Study Completion	2026-04-06 (estimated)
Updated on ClinicalTrials.gov	2026-04-21